Treating breast cancer through novel inhibitors of the phosphatidylinositol 3'-kinase pathway

Por Crowder, Robert J, Ellis, Matthew J
Publicado em 2005

A Comparison of Treated and Untreated Cases of Cancer of the Breast

Por Phillips, A. J.
Publicado em 1959

Proliferation, steroid receptors and clinical/pathological response in breast cancer treated with letrozole

Por Miller, W R, White, S, Dixon, J M, Murray, J, Renshaw, L, Anderson, T J
Publicado em 2006

P-glycoprotein expression in treated and untreated human breast cancer.

Por Schneider, J., Bak, M., Efferth, T., Kaufmann, M., Mattern, J., Volm, M.
Publicado em 1989

Influence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamide

Por Bray, J, Sludden, J, Griffin, M J, Cole, M, Verrill, M, Jamieson, D, Boddy, A V
Publicado em 2010

Do women treated for breast cancer at teaching hospitals really fare better?

Por Muckle, T.J.
Publicado em 2001

Do women treated for breast cancer at teaching hospitals really fare better?

Por Fingerote, Robert J.
Publicado em 2001

Plasma insulin-like growth factor in primary breast cancer patients treated with adjuvant chemotherapy.

Por Peyrat, J. P., Révillion, F., Bonneterre, J.
Publicado em 1998

Targeting Mdmx to treat breast cancers with wild-type p53

Por Haupt, S, Buckley, D, Pang, J-MB, Panimaya, J, Paul, P J, Gamell, C, Takano, E A, Ying Lee, Y, Hiddingh, S, Rogers, T-M, Teunisse, A F A S, Herold, M J, Marine, J-C, Fox, S B, Jochemsen, A, Haupt, Y
Publicado no Cell Death Dis (2015)

The optimal extent of resection for patients with stages I or II breast cancer treated with conservative surgery and radiotherapy.

Por Vicini, F A, Eberlein, T J, Connolly, J L, Recht, A, Abner, A, Schnitt, S J, Silen, W, Harris, J R
Publicado em 1991

Incidence and management of diarrhea in patients with HER2-positive breast cancer treated with pertuzumab

Por Swain, S. M., Schneeweiss, A., Gianni, L., Gao, J. J., Stein, A., Waldron-Lynch, M., Heeson, S., Beattie, M. S., Yoo, B., Cortes, J., Baselga, J.
Publicado no Ann Oncol (2017)

Incidence and management of diarrhea in patients with HER2-positive breast cancer treated with pertuzumab

Por Swain, S M, Schneeweiss, A, Gianni, L, Gao, J J, Stein, A, Waldron-Lynch, M, Heeson, S, Beattie, M S, Yoo, B, Cortes, J, Baselga, J
Publicado no Ann Oncol (2019)

Incidence and management of diarrhea in patients with HER2-positive breast cancer treated with pertuzumab

Por Swain, S M, Schneeweiss, A, Gianni, L, Gao, J J, Stein, A, Waldron-Lynch, M, Heeson, S, Beattie, M S, Yoo, B, Cortes, J, Baselga, J
Publicado no Ann Oncol (2018)

Prospective evaluation of prognostic value of morphometry in patients with primary breast cancer.

Por van der Linden, J C, Baak, J P, Lindeman, J, Hermans, J, Meyer, C J
Publicado em 1987

Coordinating Cancer Care: Patient and Practice Management Processes Among Surgeons Who Treat Breast Cancer

Por Katz, Steven J., Morrow, Monica, Hawley, Sarah T., Griggs, Jennifer J., Jagsi, Reshma, Hamilton, Ann S., Graff, John J., Friese, C. R., Hofer, Timothy P.
Publicado em 2010

Treating early-stage breast cancer: hospital characteristics associated with breast-conserving surgery.

Por Johantgen, M E, Coffey, R M, Harris, D R, Levy, H, Clinton, J J
Publicado em 1995

Treating young patients with breast cancer : The evidence suggests that all should be treated with adjuvant therapy

Por Dixon, J M, Hortobagyi, G
Publicado em 2000

Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer

Por Bharali, Dhruba J, Yalcin, Murat, Davis, Paul J, Mousa, Shaker A
Publicado em 2013

Comparison of mastectomy with tamoxifen for treating elderly patients with operable breast cancer.

Por Robertson, J. F., Todd, J. H., Ellis, I. O., Elston, C. W., Blamey, R. W.
Publicado em 1988

Time away from work: Employed husbands of women treated for breast cancer

Por Bradley, Cathy J., Dahman, Bassam
Publicado em 2013